β-Adrenergic signal transduction pathway in developing and aging hearts

Heart Failure Reviews

Volumn 2, Issue 1, 1997, Pages 23-41

  Das, Prasun K ^b   Temsah, Rana ^b   Panagia, Vincenzo ^b   Dhalla, Naranjan S ^a  

^a ST BONIFACE GENERAL HOSPITAL   (Canada)

^b NONE

Author keywords

adrenoceptors; Adenylyl cyclase; Aging heart; Developing heart; G proteins; Signal transduction mechanism

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP DEPENDENT PROTEIN KINASE;

AGING; ALPHA ADRENERGIC RECEPTOR BLOCKING; ARTICLE; BINDING SITE; DRUG RECEPTOR BINDING; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART DEVELOPMENT; NONHUMAN; PROTEIN CONTENT; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION;

EID: 0031392674     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009715303855     Document Type: Article

References (217)

1. Stiles GL, Lefkowitz RJ. Cardiac adrenergic receptors. Annu Rev Med 1984;35:149-164.
2. Bristow MR, Kantrowitz NE, Ginsburg R, Fowler MB. β- adrenergic function in heart muscle disease and heart failure. J Mol Cell Cardiol 1985;17:41-52.
3. Horn EM, Bilezikian JP. Mechanisms of abnormal transmembrane signaling of the β-adrenergic receptor in congestive heart failure. Circulation 1990;82:I26-I34.
4. Bogaert MG, Fraeyman N. Receptor function in heart failure. Am J Med 1991;90:10S-13S.
5. Hori M, Koretsune Y, Sato H, Kagiya T, Kitabatake A, Kamada T. Detrimental effects of beta-adrenergic stimulation on beta-adrenoceptors and microtubules in the heart. Heart Vessels 1991;6:11-17.
6. Homey CJ, Vatner SF, Vatner DE. β-Adrenergic receptor regulation in the heart in pathophysiologic states: Abnormal adrenergic responsiveness in cardiac disease. Annu Rev Physiol 1991;53:137-159.
7. Dhalla NS, Dixon IMC, Beamish RE. Biochemical basis of heart function and contractile failure. J Appl Cardiol 1991;6:7-30.
8. Dhalla NS, Dixon IMC, Suzuki S, Kaneko M, Kobayashi A, Beamish RE. Changes in adrenergic receptors during the development of heart failure. Mol Cell Biochem 1992;114:91-95.
9. Dixon IMC, Dhalla NS. Alterations in cardiac adrenoceptors in congestive heart failure secondary to myocardial infarction. Coronary Artery Disease 1991;2:805-814.
10. Van Zwieten PA. The role of adrenoceptors in circulatory and metabolic regulation. Am Heart J 1988;116:1384-1392.
11. Figueredo VM, Camacho SA. Basic mechanisms of myocardial dysfunction: Cellular pathophysiology of heart failure. Curr Opin Cardiol 1995;10:246-252.
12. Peter JB. Beta-adrenergic receptors and their regulation. Am J Respir Crit Care Med 1995;152:838-860.
13. 2-adrenoceptors in the human heart: Properties, function, and alterations in chronic heart failure. Pharmacol Rev 1991;43:203-242.
14. Raymond JR, Hnatowich M, Lefkowitz RJ, Caron M. Adrenergic receptors: Models for regulation of signal transduction processes. Hypertension 1990;15:119-131.
15. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR, Trendelenburg U. International union of pharmacology nomenclature of adrenoceptors. Pharmacol Rev 1994;46:121-136.
16. Brodde O-E, Hillemann S, Kunde K, Vogesang M, and Zerkowski H-R. Receptor systems affecting force of contraction in the human heart and their alterations in chronic heart failure. J Heart Lung Transplant 1992;11:S164-S174.
17. Bristow MR, Heshberger RE, Port JD, Gilbert EM, Sandoval A, Rasmussen R, Cates AE, Feldman AM. β-Adrenergic pathways in nonfailing and failing human ventricular myocardium. Circulation 1990;82:I12-I25.
18. Stiles GL. Adrenergic receptor responsiveness and congestive heart failure. Am J Cardiol 1991;67:13C-17C.
19. Stiles GL, Caron MG, Lefkowitz RJ. β-adrenergic receptors: Biochemical mechanisms of physiological regulation. Physiol Rev 1984;64:661-743.
20. Feldman AM. Modulation of adrenergic receptors and G-transduction proteins in failing human ventricular myocardium. Circulation 1993;87:IV27-IV34.
21. Waagstein F. Beta-adrenergic blockade in dilated cardiomyopathy, ischemic cardiomyopathy, and other secondary cardiomyopathies. Heart Vessels 1991;6:18-28.
22. Gilbert EM, O'Connell JB, Bristow MR. Therapy of idiopathic dilated cardiomyopathy with chronic β-adrenergic blockade. Heart Vessels 1991;6:29-39.
23. Brodde O-E, Michel MC, Zerkowski H-R. Signal transduction mechanisms controlling cardiac contractility and their alterations in chronic heart failure. Cardiovasc Res 1995; 30:570-584.
24. Jones CR, Molenaar P, Summers RJ. New views of human cardiac β-adrenoceptors. J Mol Cell Cardiol 1989;21:519-535.
25. Anderson K-E. Some new positive inotropic agents. Acta Med Scand Suppl 1986;707:65-73.
26. Brodde O-E. Pathophysiology of the β-adrenoceptor system in chronic heart failure: Consequences for treatment with agonists, partial agonists or antagonists. Eur Heart J 1991;12 (Suppl F):54-62.
27. Ahlquist RP. A study of the adrenotropic receptors. Am J Physiol 1948;153:586-600.
28. 2-adrenoceptors: Pharmacological and molecular biological evidence converge. Trends Pharmacol Sci 1988;9:356-361.
29. 2-adrenergic receptors. FASEB J 1992;6:832-839.
30. Tate KM, Briend-Sutren M-M, Emorine LJ, Delavier-Klutchko C, Marullo S, Strosberg AD. Expression of three human β-adrenergic receptor subtypes in transfected Chinese hamster ovary cells. Eur J Biochem 1991;196:357-361.
31. 3-adrenergic receptor. Science 1989;245:1118-1121.
32. Lands AM, Arnold A, McAuliff JP, Luduena FP, Brown TG. Differentiation of receptor systems activated by sympathomimetic amines. Nature 1967;214:597-598.
33. Lands AM, Luduena FP, Buzzo HJ. Differentiation of receptors responsive to isoproterenol. Life Sci 1967;6:2241-2249.
34. Bernstein D, Doshi R, Huang S, Strandness E, Jasper JR. Transcriptional regulation of left ventricular β-adrenergic receptors during chronic hypoxia. Circ Res 1992;71:1465-1471.
35. Brodde O-E, Zerkowski HR, Schranz D, Broede-Sitz A, Michel-Reher M, Schafer-Beisenbusch E, Piotrowski JA, Oelert H. Age-dependent changes in the β-adrenoceptor-G-protein(s)-adenylyl cyclase system in human right atrium. J Cardiovasc Pharmacol 1995;26:20-26.
36. Buxton ILO, Brunton LL. Direct analysis of β-adrenergic receptor subtypes on intact adult ventricular myocytes of the rat. Circ Res 1985;56:126-132.
37. Jones DT, Reed RR. Molecular cloning of five GTP-binding protein cDNA species from rat olfactory neuroepithelium. J Biol Chem 1987;262:14241-14249.
38. Kiuchi K, Shannon RP, Komamura K, Cohen DJ, Bianchi C, Homey CJ, Vatner SF, Vatner DE. Myocardial β-adrenergic receptor function during the development of pacing-induced heart failure. J Clin Invest 1993;91:907-914.
39. Kowalski MT, Haworth D, Lu X, Thomson DS, Barnett DB. Comparison of the effects of xamoterol and isoprenaline on rat cardiac β-adrenoceptors: Studies of function and regulation. Br J Pharmacol 1990;99:27-30.
40. 2-adrenoceptors in different human heart diseases. Naunyn-Schmiedeberg's Arch Pharmacol 1991;343:217-220.
41. Turner N, Houck WT, Boehm C, Roberts J. Cardiac β-adrenoceptor binding characteristics with age following adrenal demedullation. Br J Pharmacol 1990;99:87-90.
42. 2-adrenergic receptor: purification and characterization. Biochemistry 1984;23:4510-4518.
43. Cerione RA, Strulovici B, Benovic JL, Lefkowitz RJ, Caron MG. Pure β-adrenergic receptor: The single polypeptide confers catecholamine responsiveness to adenylate cyclase. Nature 1983;306:562-566.
44. 2-adrenergic receptor. Biochemistry 1983;22:660-668.
45. 2 subtypes revealed by peptide maps. J Biol Chem 1983;258:10689-10694.
46. 2 receptor subtypes demonstrated by photoaffinity labeling. J Biol Chem 1983;258:8443-8449.
47. Cubero A, Malbon CC. The fat cell β-adrenergic receptor. J Biol Chem 1984;259:1344-1350.
48. Dixon RAF, Kobilka BK, Strader DJ, Benovic JL, Dohlman HG, Frielle T, Bolanowski MA, Bennett CD, Rands E, Diehl RE, Mumford RA, Slater EE, Sigal IS, Caron MG, Lefkowitz RJ, Strader CD. Cloning of the gene and cDNA for mammalian β-adrenergic receptor and homology with rhodopsin. Nature 1986;321:75-79.
49. 2-adrenergic receptor: A protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci USA 1987;84:46-50.
50. s regulatory activity in response to agonists and thiols. J Biol Chem 1987;262:16655-16662.
51. Fraser CM. Site-directed mutagenesis of β-adrenergic receptors. J Biol Chem 1989;264:9266-9270.
52. s and increase agonist affinity. J Biol Chem 1987;262:16439-16443.
53. Strader CD, Sigal IS, Register RB, Candelore MR, Rands E, Dixon RAF. Identification of residues required for ligand binding to the β-adrenergic receptor. Proc Natl Acad Sci USA 1987;84:4384-4388.
54. 2-adrenergic receptor. Biochemistry 1988;27:1813-1817.
55. 2-adrenergic receptors: Delineation of domains involved in effector coupling and ligand binding specificity. Science 1988;240:1310-1316.
56. Benovic JL, Pike LJ, Cerione RA, Staniszewski C, Yoshimasa T, Codina J, Caron MG, Lefkowitz RJ. Phosphorylation of the mammalian β-adrenergic receptor by cyclic AMP-dependent protein kinase. J Biol Chem 1985;260:7094-7101.
57. Benovic JL, Strasser RH, Caron MG, Lefkowitz RJ. β-Adrenergic receptor kinase: Identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor. Proc Natl Acad Sci USA 1986;83:2797-2801.
58. 1-adrenergic receptor. Proc Natl Acad Sci USA 1987;84:7920-7924.
59. Gocayne J, Robinson DA, FitzGerald MG, Chung F-Z, Kerlavage AR, Lentes K-U, Lai J, Wang C-D, Fraser CM, Venter JC. Primary structure of rat cardiac β-adrenergic and muscarinic cholinergic receptors obtained by automated DNA sequence analysis: Further evidence for a multigene family. Proc Natl Acad Sci USA 1987;84:8296-8300.
60. Yarden Y, Rodriguez H, Wong SK-F, Brandt DR, May DC, Burnier J, Harkins RN, Chen EY, Ramachandran J, Ullrich A, Ross EM. The avian β-adrenergic receptor: Primary structure and membrane topology. Proc Natl Acad Sci USA 1986;83:6795-6799.
61. 2-adrenergic receptors. Proc Natl Acad Sci USA 1988;85:9494-9498.
62. 2-adrenergic receptor: Reconstitution of functional interactions between pure receptor and pure stimulatory nucleotide binding protein of the adenylate cyclase system. Biochemistry 1984;23:4519-4525.
63. Scarpace PJ, Matheny M. Adenylate cyclase agonist properties of CGP-12177A in brown fat: Evidence for atypical β-adrenergic receptors. Am J Physiol 1991;260:E226-E231.
64. 1-adrenergic receptor gene. J Biol Chem 1990;265:12960-12965.
65. Bristow MR, Sandoval AB, Gilbert EM, Deisher T, Minobe W, Rasmussen R. Myocardial α- and β-adrenergic receptors in heart failure: Is cardiac derived norepinephrine the regulatory signal. Eur Heart J 1988;9:35-40.
66. Fowler MB, Laser JA, Hopkins GL, Minobe W, Bristow MR. Assessment of the β-adrenergic receptor pathway in the intact failing human heart: Progressive receptor down-regulation and subsensitivity to agonist response. Circulation 1986;74:1290-1302.
67. Port JD, Bristow MR. Lack of spare β-adrenergic receptors in human heart. (Abstract). FASEB J 1988;2:A602.
68. 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium. Circ Res 1986;69:297-309.
69. 2-adrenoceptors in human atrial myocardium. Cire Res 1990;66:1610-1623.
70. Waelbroeck M, Taton G, Delhaye M, Chatelain P, Camus JC, Pochet R, Leclerc JL, De Smet JM, Robberecht P, Christophe J. The human heart β-adrenergic receptors. Mol Pharmacol 1983;24:174-182.
71. 2 receptors are coupled to adenylyl cyclase in human ventricular myocardium. Circ Res 1986;59:297-308.
72. 2-adrenoceptor-mediated positic einotropic effect of adrenaline in human ventricular myocardium. Naunyn-Schmiedeberg's Arch Pharmacol 1987;335: 403-411.
73. 2 subtypes by radioligand binding. Br J Pharmacol 1983;80:711-717.
74. 2-adrenoceptors in human right atrium. Circ Res 1983;53:752-758.
75. 2-adrenoceptors in the human atrioventricular conducting system: A comparison of patients with idiopathic dilated cardiomyopathy and ischemic heart disease. J Mol Cell Cardiol 1994;26:313-323.
76. 2-adrenoceptors are functionally coupled to the adenylyl cyclase in human right atrium. J Cardiovasc Pharmacol 1984;6:1184-1191.
77. Witte K, Parsa-Parsi R, Vobig M, Lemmer B. Mechanisms of the circadian regulation of β-adrenoceptor density and adenylyl cyclase activity in cardiac tissue from normotensive and spontaneously hypertensive rats. J Mol Cell Cardiol 1995;27:1195-1202.
78. Rall TW, Sutherland EW, Berthat J. The relationship of epinephrine and glucagon to liver phosphorylase. IV. Effect of epinephrine and glucagon on the reactivation of phosphorylase in liver homogenates. J Biol Chem 1957;224:463-475.
79. Rodbell M, Birnbaumer L, Pohl SL, Crans HMJ. The glucagon sensitive adenylyl cyclase system in plasma membrane of rat liver. J Biol Chem 1971;246:1877-1892.
80. Rodbell M, Crans HMJ, Pohl SL, Birnbaumer L. The glucagon sensitive adenylyl cyclase system in plasma membrane of rat liver. IV. Binding of glucagon: Effect of guanyl nucleotides. J Biol Chem 1971;246:1872-1876.
81. Krishna G, Harwood JP, Barber AJ, Jamieson GA. Requirement of guanosine triphosphate in the prostaglandin activation of adenylyl cyclase of platelet membranes. J Biol Chem 1972;247:2253-2254.
82. Pfeuffer T, Helmreich EJM. Activation of pigeon erythrocyte membrane adenylate cyclase by guanyl nucleotides analog and separation nucleotide binding protein. J Biol Chem 1975;255:867-876.
83. Rodbell M. The role of hormone receptors and GTP regulatory proteins in membrane transduction. Nature 1980;287: 297-300.
84. Cerione RA, Staniszewski C, Gierschik P, Codina J, Somers RL, Birnbaumer L, Spiegel AM, Caron MG, Lefkowitz RJ. Mechanism of guanine nucleotide regulatory protein mediated inhibition of adenylate cyclase. J Biol Chem 1986;261: 9514-9520.
85. 2-subunits of regulatory guanine nucleotide-binding proteins. Biochem Biophys Acta 1989;1013:60-67.
86. Meij JTA. Regulation of G protein function: Implications for heart disease. Mol Cell Biochem 1996;157:31-38.
87. Clapham DE, Neer EJ. New roles for G-protein βγ-dimers in transmembrane signalling. Nature 1993;365:403-406.
88. Gilman AG. G-proteins: Transducers of receptor-generated signals. Annu Rev Biochem 1987;56:615-649.
89. Tang ZL, Scherer PE, Okamoto T, Song K, Chu C, Kohtz DS, Nishimoto I, Lodish HF, Lisanti MP. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 1996;271: 2255-2261.
90. Katada T, Bokoch GM, Smigel MD, Ui M, Gilman AG. The inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase. J Biol Chem 1984;259:3586-3595.
91. Bristow MR, Cubicciotti R, Ginsburg R, Stinson EB, Johnson C. Histamine-mediated adenylate cyclase stimulation in human myocardium. Mol Pharmacol 1982;21:671-679.
92. 2-receptor agonist impromidine in human myocardium from patients with heart failure due to mitral and aortic valve disease. J Cardiovasc Pharmacol 1983;5:618-625.
93. Hershberger RE, Anderson FL, Bristow MR. Vasoactive intestinal peptide receptor in failing human ventricular myocardium exhibits increased affinity and decreased density. Circ Res 1989;65:283-294.
94. Kaumann AJ, Sanders L, Brown AM, Murray KJ, Brown MJ. A 5-hydroxytryptamine receptor in human atrium. Br J Pharmacol 1990;100:879-885.
95. 4-like receptor in human right atrium. Naunyn-Schmiedeberg's Arch Pharmacol 1991;344:150-159.
96. 4-like receptor in human left atrium. Naunyn Schmiedeberg's Arch Pharmacol 1992;345:382-386.
97. Zerkowski H-R, Broede A, Kunde K, Hillemann S, Schafer E, Vogelsang M, Michel MC, Brodde-OE. Comparison of the positive inotropic effects of serotonin, histamine, angiotensin II, endothelin and isoprenaline in the isolated human right atrium. Naunyn-Schmiedeberg's Arch Pharmacol 1993;347:347-352.
98. Ferro A, Plumpton C, Brown MJ. Is receptor cross-regulation in human heart caused by alterations in cardiac guanine nucleotide-binding proteins? Clin Sci 1993;85:393-399.
99. Gilman AG. G-proteins and dual control of adenylate cyclase. Cell 1984;36:577-579.
100. 21 current in single rat ventricular cells. Circ Res 1993;73:286-300.
101. sα gene. Proc Natl Acad Sci USA 1988;85:2018-2085.
102. Lai E, Rosen OM, Rubin CS. Differentiation dependent expression of catecholamine-stimulated adenylate cyclase. Roles of the β-receptor and G/F protein in differentiating 3T3-L1 adipocytes. J Biol Chem 1981;256:12866-12874.
103. Lynch CJ, Blackmore PF, Johnson EH, Wanga RL, Krona PK, Exton JH. Guanine-nucleotide binding regulatory protein and adenylate cyclase in livers of streptozocin and BB/Wor-diabetic rats: Immunodetection of Gs and Gi with antisera prepared against synthetic peptides. J Clin Invest 1989;83:2050-2062.
104. sα-stimulate adenylate cyclase. J Biol Chem 1987;262:11375-11381.
105. Casey PJ, Gilman AG. G protein involvement in receptor effector coupling. J Biol Chem 1988;263:2577-2580.
106. Yatani A, Codina J, Imoto Y, Reeves JP, Birnbaumer L, Brown AM. A G protein directly regulates mammalian cardiac calcium channel. Science 1987;238:1288-1292.
107. Witte K, Schnecke A, Olbrich HG, Lemmer B. Efficiency of β-adrenoceptor subtype coupling to cardiac adenylyl cyclase in cardiomyopathy and control hamsters. Eur J Pharmacol 1995;290:1-10.
108. Harris RA, Robinshow JD, Mumby SM, Gilman AG. Molecu- lar cloning of complementary DNA for the α-subunit of the G-protein that stimulates adenylate cyclase. Science 1985;229:1274-1277.
109. Robinshaw JD, Russel DW, Harris BA, Smigel MD, Gilman AG. Deduced primary structure of the alpha subunit of the GTP-binding stimulatory protein of adenylate cyclase. Proc Natl Acad Sci USA 1986;83:1251-1255.
110. Yatsunami K, Pandya BR, Aprian DD, Khorana HG, cDNA derived amino acid sequence of the gamma subunit of GTPase from the bovine rod outer segments. Proc Natl Acad Sci USA 1985;82:1936-1940.
111. iα-2 gene transcriptional activity in rat heart. J Mol Cell Cardiol 1994;26:869-875.
112. Ueda N, Iniguez-Lluhi JA, Lee E, Smrcka AV, Robishaw JD, Gilman AG. G protein βγ subunits. J Biol Chem 1994;269:4388-4395.
113. Watson AJ, Katz A, Simon MI. A fifth member of the mammalian G-protein β-subunit family. J Biol Chem 1994;269: 22150-22156.
114. Müller S, Hekman M, Lohse MJ. Specific enhancement of β-adrenergic receptor kinase activity by defined G-protein β and γ subunits. Proc Natl Acad Sci USA 1993;90:10439-10443.
115. Kunkel MT, Peralta EG. Identification of domains conferring G protein regulation on inward rectifier potassium channels. Cell 1995;83:443-449.
116. KACH. J Biol Chem 1995;270:29059-29062.
117. Holmer SR, Stevens S, Homey CJ. Tissue- and species-specific expression of inhibitory guanine nucleotide-binding proteins. Cloning of a full-length complementary DNA from canine heart. Cire Res 1989;65:1136-1140.
118. sα protein mRNA in rat ventricular myocardium with aging. Eur J Pharmacol 1994;266:147-154.
119. Ishikawa Y, Katsushika S, Chen L, Halnon NJ, Kawabe J-I, Homey CJ. Isolation and characterization of a novel cardiac adenylyl cyclase cDNA. J Biol Chem 1992;267:13553-13557.
120. Katsushika S, Chen L, Kawabe J-I, Nilakantan R, Halnon NJ, Homey CJ, Ishikawa Y. Cloning and characterization of a sixth adenylyl cyclase isoform: Types V and VI constitute a subgroup within the mammalian adenylyl cyclase family. Proc Natl Acad Sci USA 1992;89:8774-8778.
121. Watanabe AM, McConnaughey MM, Strawbridge RA, Fleming JW, Jones LR, Besch HR Jr. Muscarinic cholinergic receptor modulation of β-adrenergic receptor affinity for catecholamines. J Biol Chem 1978;28:4833-4836.
122. Feldmann AM, Cates AE, Veazey WB, Hershberger RE, Bristow MR, Baughman KG, Baugmartner WA. Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. J Clin Invest 1988;82:189-197.
123. Sunahara RK, Dessaur CW, Gilman AG. Complexity and diversity of mammalian adenylyl cyclases. Review Pharmacol Toxicol 1996;36:461-480.
124. Yu HJ, Unnerstall JR, Green RD. Determination and cellular localization of adenylyl cyclase isozymes expressed in embryonic chick heart. FEBS Lett 1995;374:89-94.
125. Tang WJ, Krupinski J, Gilman AG. Expression and characterization of calmodulin activated (type I) adenylate cyclase. J Biol Chem 1991;266:8595-8603.
126. 21/calmodulin-stimulated enzyme expressed in discrete regions of rat brain. J Biol Chem 1994;269:12190-12195.
127. 21-inhibitable adenylyl cyclase from NCB-20 cells. Proc Natl Acad Sci USA 1992;89:6716-6720.
128. Wallach J, Droste M, Kluxen FW, Pfeuffer T, Frank R. Molecular cloning and expression of a novel type V adenylate cyclase from rabbit myocardium. FEBS Lett 1994;338:257-263.
129. Smigel MD. Purification of the catalyst of adenylyl cyclase. J Biol Chem 1986;261:1976-1982.
130. Krupinski J, Coussen F, Bakalyar HA, Tang W-J, Feinstein PG, Orth K, Slaughter C, Reed RR, Gilman AG. Adenylyl cyclase amino acid sequence: Possible channel- or transporter-like structure. Science 1989;244:1558-1564.
131. Gaudin C, Homcy CJ, Ishikawa Y. Mammalian adenylyl cyclase family members are randomly located on different chromosomes. Hum Genet 1994;94:527-529.
132. Watson PA, Krupinski J, Kempinski AM, Frankenfield CD. Molecular cloning and characterization of the type VII isoform of mammalian adenylyl cyclase expressed widely in mouse tissues and in S49 mouse lymphoma cells. J Biol Chem 1994;269:28893-28898.
133. Pieroni JP, Harry A, Chen J, Jacobowitz O, Magnusson RP, Iyengar R. Distinct characteristics of the basal activities of adenylyl cyclases 2 and 6. J Biol Chem 1995;270:21368-21373.
134. Birnbaumer L, Codina J, Mattera R, Carione RA, Hildebrndt JD, Sunyer T, Rojas F, Caron MG, Lefkowitz RJ, Iyenger R. Regulation of hormone receptors and adenylate cyclase by guanine nucleotide binding N-protein. Recent Prog Horm Res 1985;41:41-49.
135. Tsien, RW Cyclic AMP and contractile activity in the heart. Adv Cyclic Nucleotide Res 1977;8:363-420.
136. Krebs EG, Beavo JA. Phosphorylation and dephosphorylation of enzymes. Annu Rev Biochem 1979;48:923-956.
137. Taylor SS, Knighton DR, Zheng J. Structural framework for the protein kinase family. Annu Rev Cell Biol 1992;8:429-462.
138. Francis SH, Corbin JD. Structure and function of cyclic nucleotide-dependent protein kinases. Annu Rev Physiol 1994;56:237-272.
139. Haase H, Karczewski P, Beckert R, Krause EG. Phosphorylation of the L-type calcium channel β subunit is involved in β-adrenergic signal transduction in canine myocardium. FEBS Lett 1993;335:217-222.
140. Marsh JD. Myocyte response to stimulation of receptors and ion channels. Toxicol Pathol 1990;18:454-463.
141. Fu L-X, Waagstein F, Hjalmarson Å. G protein and calcium channels in myocardium. Life Sci 1991;48:2291-2295.
142. 21 channels by β-adrenergic agonists. Proc Natl Acad USA 1996;93:295-299.
143. Wegener AD, Simmerman HKB, Lindemann JP, Jones LR. Phospholamban phosphorylation in intact ventricles. J Biol Chem 1989;264:11468-11474.
144. Talosi L, Edes I, Kranias EG. Intracellular mechanisms mediating reversal of β-adrenergic stimulation in intact beating hearts. Am J Physiol 1993;264:H791-H797.
145. Strang KT, Sweitzer NK, Greaser ML, Moss RL. β-Adrenergic receptor stimulation increases unloaded shortening velocity of skinned single ventricular myocytes from rats. Circ Res 1994;74:542-549.
146. 2-adrenoceptor function. Naunyn-Schmiedeberg's Arch Pharmacol 1990;342:429-435.
147. Benovic JL, Bouvier M, Caron MG, Lefkowitz RJ. Regulation of adenylyl cyclase-coupled β-adrenergic receptors. Annu Rev Cell Biol 1988;4:405-428.
148. Perkins JP, Hausdorff WP, Lefkowitz RJ. Mechanisms of ligand-induced desensitization of β-adrenergic receptors. In: Perkins JP, ed. The β-Adrenergic Receptors. Clifton, NJ: The Humana Press, 1991:73-124.
149. 1-induced translocation of the β-adrenergic receptor kinase: Evidence that the kinase may act on multiple adenylate cyclase-coupled receptors. Proc Natl Acad Sci USA 1986;83:6362-6366.
150. Inglese J, Freedman NJ, Koch WJ, Lefkowitz RJ. Structure and mechanism of the G protein-coupled receptor kinases. J Biol Chem 1993;268:23735-23738.
151. Benovic JL, Mayor F Jr, Staniszewski C. Purification and characterization of the β-adrenergic receptor kinase. J Biol Chem 1987;262:9026-9032.
152. 2-adrenergic receptor are involved in distinct pathways of receptor desensitization. J Biol Chem 1989;264:12657-12665.
153. Lohse MJ, Andexinger S, Pitcher J, Trukawinski S, Codina J, Faure J-P, Caron MG, Lefkowitz RJ. Receptor-specific desensitization with purified proteins. J Biol Chem 1992;267:8558-8564.
154. Gurevich VV, Dion SB, Onorato JJ, Ptasienski J, Kim CM, Sterne-Marr R, Hosey MM, Benovic JL. Arrestin interactions with G protein-coupled receptors. J Biol Chem 1995;270:720-731.
155. Lohse MJ, Benovic JL, Codina J, Caron MG, Lefkowitz RJ. β-Arrestin: A protein that regulates β-adrenergic receptor function. Science 1990;248:1547-1549.
156. Parruti G, Peracchia F, Sallese M, Ambrosini G, Masini M, Rotilio D, DeBlasi A. Molecular analysis of human β-arrestin-1: Cloning, tissue distribution, and regulation of expression. J Biol Chem 1993;268:9753-9761.
157. 2-adrenergic receptor gene in response to short-term agonist exposure. Proc Natl Acad Sci USA 1989;86:4853-4857.
158. Söhlemann P, Hekman M, Puzicha M, Buchen C, Lohse MJ. Binding of purified recombinant β-arrestin to guanine-nucleotide-binding-protein-coupled receptors. Eur J Biochem 1995;232:464-472.
159. Collins S, Caron MJ, Lefkowitz RJ. From ligand binding to gene expression: New insights into the regulation of G-protein-coupled receptors. Trends Biochem Sci 1992;17:37-39.
160. Hausdorff WP, Caron MG, Lefkowitz RJ. Turning off the signal: Disensitization of β-adrenergic receptor function. FASEB J 1990;4:2881-2889.
161. Clark RB, Friedman J, Dixon RAF, Strader CD. Identification of a specific site required for rapid heterologous desensitization of the β-adrenergic receptor by cAMP-dependent protein kinase. Mol Pharmacol 1989;36:343-348.
162. Ma Z, Meddings JB, Lee SS. Membrane physical properties determine cardiac β-adrenergic receptor function in cirrhotic rats. Am J Physiol 1994;267:G87-G93.
163. Alam SQ, Mannino SJ, Alam BS, McDonough K. Effect of essential fatty acid deficiency on forskolin binding sites, adenylate cyclase and cyclic AMP-dependent protein kinase activity, the levels of G proteins and ventricular function in rat heart. J Mol Cell Cardiol 1995;27:1593-1604.
164. Limas CJ, Limas C. Rapid recovery of cardiac β-adrenergic receptors after isoproterenol-induced "down"-regulation. Circ Res 1984;55:524-531.
165. Buznikov GA, Kost AN, Berdysheva LV. The role of neurohumours in early embryogenesis. 3. Pharmacological analysis of the role of neurohumours in cleavage divisions. J Embryol Exp Morphol 1970;23:549-569.
166. Lovell J. Effects of 6-hydroxydopamine-induced norepinephrine depletion on cerebellar development. Dev Neurosci 1982;5:359-368.
167. Pappano AJ. Adrenoceptors and adrenergic mechanisms in the embryonic and fetal heart. In: Kunos G, ed. Adrenoceptors and Catecholamine Action. New York: Wiley, 1981:69-97.
168. Slotkin TA. Development of the sympathoadrenal axis. In: Gootman PM, ed. Development of Neurobiology of the Autonomic Nervous System. Clifton, NJ: Humana Press, 1986: 69-96.
169. Slotkin TA. Endocrine control of synaptic development in the sympathetic nervous system: The cardiac sympathetic axis. In: Gootman PM, ed. Development of Neurobiology of the Autonomic Nervous System. Clifton, NJ: Humana Press, 1986:97-133
170. Cochard P, Goldstein M, Black IB. Ontogenetic appearance and disappearance of tyrosine hydroxylase and catecholamines in the rat embryo. Proc Natl Sci USA 1978;75:2986-2990.
171. Jonakait GM, Wolf J, Cochard P, Goldstein M, Black IB. Selective loss of noradrenergic phenotypic characters in neuroblasts of rat embryo. Proc Natl Acad Sci USA 1979;76:4683-4686.
172. Robkin M, Shepard TH, Dyer DC. Autonomie receptors of the early rat embryo heart: Growth and development. Proc Soc Exp Biol Med 1976;151:799-803.
173. Navarro HA, Kudlacz EM, Slotkin TA. Control of adenylate cyclase activity in developing rat heart and liver. Effects of prenatal exposure to terbutaline or dexamethasone. Biol Neonate 1991;60:127-136.
174. Slotkin TA, Whitmore WL, Orband-Miller L, Queen KL, Haim K. Beta adrenergic control of macromolecule synthesis in neonatal rat heart, kidney and lung: Relationship to sympathetic neuronal development. J Pharmacol Exp Ther 1987;243:101-109.
175. Lau C, Burke SP, Slotkin TA. Maturation of sympathetic neurotransmission in the rat heart. IX. Development of transsynaptic regulation of cardiac adrenergic sensitivity. J Pharmacol Exp Ther 1982;223:675-680.
176. Stein HM, Oyama K, Sapien R, Chappell BA, Padbury JF. Prolonged β-agonist infusion does not induce desensitization or down-regulation of β-adrenergic receptors in newborn sheep. Pediatr Res 1992;31:462-467.
177. Slotkin TA, Lau C, Seidler FJ. β-Adrenergic receptor overexpression in the fetal rat: Distribution, receptor subtypes, and coupling to adenylate cyclase activity via G-proteins. Toxicol Appl Pharmacol 1994;129,223-234.
178. Whitesett JA, Darovec-Beckerman C. Developmental aspects of β-adrenergic receptors and catecholamine-sensitive adenylate cyclase in rat myocardium. Pediatr Res 1981;15: 1363-1369.
179. 2-Adrenergic receptor actions in neonatal and adult rat ventricular myocytes. Circ Res 1995;76:40-52.
180. 2-adrenergic stimulation. Circulation 1995;92:1512-1618.
181. Bryan LJ, Cole JJ, O'Donnell SR, Wanstall JC. A study designed to explore the hypothesis that beta-1 adrenoceptors are 'innervated' receptors and beta-2 adrenoceptors are 'hormonal' receptors. J Pharmacol Exp Ther 1981;216:395-400.
182. Cerbai E, Guerra L, Varani K, Barbieri M, Borea PA, Mugelli A. Beta-adrenoceptor subtypes in young and old rat ventricular myocytes: A combined patch-clamp and binding study. Br J Pharmacol 1995;116:1835-1842.
183. Tobise K, Ishikawa Y, Holmer SR, Im MJ, Newell JB, Yoshie H, Fujita M, Susannie EE, Homey CJ. Changes in type VI adenylyl cyclase isoform expression correlate with a decreased capacity for cAMP generation in aging ventricle. Circ Res 1994;74:596-603.
184. Clark JB, Vinicor F, Carr L, Clark CM. Adenylyl cyclase responsiveness to guanyl nucleotides in the developing rat heart. Pediatr Res 1980;14:291-295.
185. Chen FMC, Yamamura HI, Roeske WR. Adenylate cyclase and beta-adrenergic receptor in the mouse heart. J Pharmacol Exp Ther 1982;222:7-13.
186. Hatjis CG. Forskolin-stimulated adenylate cyclase activity in fetal and adult rabbit myocardial membranes. Am J Obstet Gynecol 1986;155:1326-1331.
187. Espinasse I, Iourgenko V, Defer N, Samson F, Hanoune J, Mercadier JJ. Type V, but not type VI, adenylyl cyclase mRNA accumulates in the rat heart during ontogenic development. Correlation with increased global adenylyl cyclase activity. J Mol Cell Cardiol 1995;27:1789-1795.
188. Kumar R, Joyner RW, Hartzell HC, Ellingsen D, Rishi F, Eaton DC, Lu C, Akita T. Postnatal changes in the G-proteins, cyclic nucleotides and adenylyl cyclase activity in rabbit heart cells. J Mol Cell Cardiol 1994;26:1537-1550.
189. Slotkin TA, Lorber BA, McCook EC, Barnes GA, Seider FJ. Neural input and the development of adrenergic intracellular signaling: Neonatal denervation evokes neither receptor upregulation nor persistent supersensitivity of adenylate cyclase. Brain Res Dev Brain Res 1995;88:17-29.
190. Steinberg SF, Rosen TS, Malfatto G, Rosen MR. Beta adrenergic modulation of cardiac rhythm in a rat model of altered sympathetic neural development. J Mol Cell Cardiol 1991;23:47-52.
191. Xiao R-P, Lakatta EG. Deterioration of β-adrenergic modulation of cardiovascular function with aging. Ann NY Acad Sci 1992;26:293-310.
192. Yin FC, Spurgeon HA, Greene HL, Lakatta EG, Weisfeldt ML. Age-associated decrease in heart rate response to isoproterenol in dogs. Mech Aging Dev 1979;10:17-25.
193. O'Connor SW, Scarpace PJ, Abrass IB. Age-associated decrease of adenylate cyclase activity in rat myocardium. Mech Aging Dev 1981;16:91-95.
194. Sakai M, Danziger RS, Xiao R-P, Spurgeon HA, Lakatta EG. Contractile response of individual cardiac myocytes to norepinephrine declines with senescence. Am J Physiol 1992;262:H184-H189.
195. Guarnieri T, Filburn CR, Zitnik G, Roth GS, Lakatta EG. Contractile and biochemical correlates of β-adrenergic stimulation of the aged heart. Am J Physiol 1980;239:H501-H508.
196. Lakatta EG, Gerstenblith G, Angell CS, Shock NW, Weisfeldt ML. Diminished inotropic response of aged myocardium to catecholamines. Circ Res 1975;36:262-269.
197. Jiang MT, Moffat MP, Narayanan N. Age-related alterations in the phosphorylation of sarcoplasmic reticulum and myofibrillar proteins and diminished contractile response to isoproterenol in intact rat ventricle. Circ Res 1993;72:102-111.
198. Ferrara N, O'Gara P, Wynne DG, Brown LA, DelMonte F, Poole-Wilson PA, Harding SE. Decreased contractile responses to isoproterenol in isolated cardiac myocytes from aging Guinea-pigs. J Mol Cell Cardiol 1995;27:1141-1150.
199. Lakatta EG, Yin FC. Myocardial aging: Functional alterations and related cellular mechanisms. Am J Physiol 1982;242:H927-H941.
200. Scarpace PJ. Decreased beta-adrenergic responsiveness during senescence. Fed Proc 1986;45:51-54.
201. Scarpace PJ, Abrass IB. Beta-adrenergic agonist-mediated desensitization in senescent rats. Mech Aging Dev 1986; 35:255-264.
202. Abrass IB, Davis JI, Scarpacwe PJ. Isoproterenol responsiveness and myocardial beta-adrenergic receptors in young and old rats. J Gerontol 1982;37:156-160.
203. Narayanan N, Derby JA. Alterations in the properties of beta-adrenergic receptors of myocardial membranes in aging: Impairments in agonist-receptor interactions and guanine nucleotide regulation accompany diminished catecholamine-responsiveness of adenylate cyclase. Mech Aging Dev 1982;18:127-139.
204. Bouanani N, Corsin A, Gilson N, Crozatier B. Beta-adrenoceptors and adenylyl cyclase activity in hypertrophied and failing rabbit left ventricle. J Mol Cell Cardiol 1991;23:573-581.
205. Bristow MR, Anderson FL, Port D, Skerl L, Hershberger RE, Larrabee P. Differences in β-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy. Circulation 1991;84:1024-1039.
206. Scarpace PJ. Decreased receptor activation with age. Can it be explained by desensitization? J Am Geriatr Soc 1988;36:1067-1071.
207. Scarpace PJ. Forskolin activation of adenylate cyclase in rat myocardium with age: Effects of guanine nucleotide analogs. Mech Aging Dev 1990;52:169-178.
208. O'Conner SW, Scarpace PJ, Abrass IB. Age-associated decrease in the catalytic unit activity of rat myocardial adenylate cyclase. Mech Aging Dev 1983;21:357-363.
209. Urasawa K, Murakami T, Yasuda H. Age-related alterations in adenylyl cyclase system of rat hearts. Jpn Circ J 1991;55:676-684.
210. iα- proteins in rat heart. Biochem Pharmacol 1994;48:479-486.
211. 1-adrenergic receptor, Gsa and total myosin heavy chain messenger RNAs in the left ventricle of senescent rat heart. Mech Aging Dev 1993;71:169-188.
212. Johnson MD, Zhou Y, Friedman E, Roberts J. Expression of G protein α subunits in the aging cardiovascular system. J Gerontol Biol Sci Med Sci 1995;50A:B14-B19.
213. Sakai M, Danziger RS, Staddon JM, Lakatta EG, Hansford RG. Decrease with senescence in the norepinephrine-induced phosphorylation of myofilament proteins in isolated rat cardiac myocytes. J Mol Cell Cardiol 1989;21:1327-1336.
214. Dobson JG, Fenton RA. Adenosine inhibition of beta-adrenergic induced responses in aged hearts. Am J Physiol 1993;265:H494-H503.
215. Dobson JG, Fenton RA, Romano FD. Increased myocardial adenosine production and reduction of β-adrenergic contractile response in aged hearts. Circ Res 1990;66:1381-1390.
216. Neumann J, Gupta RC, Jones LR, Bodor GS, Bartel S, Krause E-G, Pask HT, Schmitz W, Scholz H, Watanabe AM. Interaction of β-adrenoceptor and adenosine receptor agonists on phosphorylation. Identification of target pro- teins in mammalian ventricles. J Mol Cell Cardiol 1995;27:1655-1667.
217. Ping P, Gelzer-Bell R, Roth DA, Kiel D, Insel PA, Hammond HK. Reduced β-adrenergic receptor activation decreases G-protein expression and β-adrenergic receptor kinase activity in porcine heart. J Clin Invest 1995;95:1271-1280.